Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q3 2016 · 10-Q
Revenue$2.94M$2.94M−29.2% vs Q3 2015 Net Income-$1.90M-$1.90MN/M vs Q3 2015 EPS Diluted-$0.04-$0.04N/M vs Q3 2015 Gross Profit$1,888,949−23.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived-$523,617N/M Free Cash Flowderived-$540,824N/M Margins · derivedGross margin64.3%+5.0 pt vs Q3 2015
Operating margin-53.7%−32.0 pt vs Q3 2015
Net margin-64.7%−40.8 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 1, 2016 · 32 d after period end